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879 
New Insights Into Resynchronization 
Therapy
Wednesday, March 10, 2004, 10:30 a.m.-Noon
Morial Convention Center, La Louisiane C
10:30 a.m.
879-1 Acute Changes in Aortic Time-Velocity-Integral With 
Cardiac Resynchronization Therapy Predict Clinical 
Outcome
Sanjeev Garhwal, Alan Waggoner, Navinder Sawhney, Mohit Chawla, Mitchell Faddis, 
Washington University, St. Louis, MO
Background: Cardiac resynchronization therapy (CRT) can improve symptoms in patients
(pts) with end-stage heart failure and ventricular conduction delay. However, up to one-
third of pts who undergo CRT fail to have clinical improvement. We hypothesized that pts
who have an acute improvement in Doppler-determined aortic time-velocity-integral
(AoTVI) with CRT are more likely to have an improvement in NYHA class at follow up.
Methods: AoTVI was measured at baseline (without pacing) and with biventricular pacing
(VDD mode) by continuous-wave Doppler echocardiography in 30 consecutive pts who
received CRT. AV delay was 125+25ms for the group. All measurements were performed
within 24 hours after CRT. Left ventricular lead position was mid-lateral in 18/30 pts. Pts
were classified as responders (n=22) or non-responders (n=8) based on improvement in
NYHA class at a 3-month follow-up. Results: There were no significant differences
between responders and non-responders in baseline NYHA class (3.1+0.4 vs 2.8+0.4;
p=0.09), ejection fraction (25%+6% vs 26+7; p=0.58), age (57+11 yrs vs 63+14 yrs;
p=0.38) and AoTVI (16.9+3.2cm vs 19.8+5.6cm; p=0.13), respectively. The mean
decrease in NYHA class at follow up was 0.9 among responders. Responders had a sig-
nificantly higher percent improvement in AoTVI with CRT compared to baseline than non-
responders (22%+13% vs 5%+6%, respectively, p=0.003). A >10% improvement in
AoTVI with CRT accurately identified pts with improved NYHA class at 3-month follow-up
(sensitivity 86%, specificity 88%, positive predictive value 95% and negative predictive
value 70%). Conclusion: A 10% improvement in AoTVI with CRT is a sensitive and spe-
cific criterion for predicting pts who will benefit from CRT. Measurement of AoTVI during
placement of the left ventricular lead could provide a simple method to assess efficacy of
CRT.
10:45 a.m.
879-2 Does Heart Rate Regularization With Biventricular 
Pacing Itself Enhance Net Cardiac Function in Heart 
Failure Patients With Chronic Atrial Fibrillation?
Ilan Hay, Vojta Melenovsky, Barry J. Fetics, Joshua Hare, Daniel Judge, Andrew Kramer, 
Craig Reister, Joe Pastore, Rick Conville, David A. Kass, Ronald Berger, Johns Hopkins 
Medical Institution, Baltimore, MD, Guidant Co., St. Paul, MN
Ventricular pacing in patients with atrial fibrillation (AF) reduces RR interval variability
(rate regularization) but can adversely influence contractile function.The latter may be
ameliorated by bi-ventricular pacing, but the added impact of rate regularization has
remained unclear. To test this, we studied nine patients with chronic AF (s/p AV-node
ablation, or with bradycardia) and cardiac failure (EF<30%). Bi-ventricular pacing was
instituted using an RV-apical and LV-postero-lateral lead. AF (using Bi-V pacing) was
simulated by a Poisson distribution of RR intervals with a mean of 80 bpm (RR: 400-
1500ms). LV and aortic micro-manometer pressures were assessed during two-minutes
recordings of simulated AF and compared to fixed rate biventricular pacing and RV pac-
ing at the same mean rate (Table).
Mean systolic function during simulated-AF was not statistically different (p>0.4 for all
comparisons, paired t-test) from that with constant rate Bi-V pacing. Diastolic function
(mean LV dp/dt min) differed between Bi-V fixed rate and Pseudo AF pacing. Bi-V pacing
improved LV performance compared to RV pacing. Thus, while rate regularization alone
narrows temporal hemodynamic variance, averaged cardiac performance is minimally
altered compared to constant rate pacing. This suggests that hemodynamic benefits of
AF pacing in heart failure patients are from BiV versus RV pacing, whereas rate regular-
ization has little effect on mean function.
11:00 a.m.
879-3 Utility of Atrioventricular Delay Optimization in Patients 
Undergoing Cardiac Resynchronization Therapy
Navin Kedia, Deborah Agler, Zoran B. Popovic, Betty Ching, Bruce Wilkoff, Richard A. 
Grimm, Cleveland Clinic Foundation, Cleveland, OH
Background: Optimization of the atrio-ventricular delay (AV delay) using Doppler
echocardiography in patients undergoing Cardiac Resynchronization Therapy (CRT) is
currently being performed inconsistently and with little data to either support or refute its
utility. We reviewed our experience with AV optimization at the Cleveland Clinic in an
attempt to provide insights into the potential utility of performing this procedure.
Methods: Data was collected from 116 patients who underwent an AV optimization
within 3 months of implant at the Cleveland Clinic between 1999 and 2002. All patients
arrived to the echocardiography laboratory with an AV delay empirically programmed by
the operator at the time of the biventricular pacemaker procedure. The AV delay was then
optimized using the method described by Ritter and colleagues and modified so as to tar-
get stage I diastolic filling as determined by Doppler echocardiography in those cases in
which the Ritter derived “optimal AV delay” was unable to be calculated due to technical
reasons. Baseline clinical characteristics, AV delay at baseline as well as the final setting
were recorded along with the stage of diastolic filling.
Results: Between 1999 and 2002 276 patients underwent a biventricular pacing implant
at the Cleveland Clinic, 116 of which also underwent an AV optimization procedure within
90 days of their implant. The average, median and range of AV delays were 129, 130, 50-
180 msec respectively at baseline while the average, median and range of final AV delay
settings were 133, 130, 50-250 msec respectively. In 78% of cases the final AV delay set-
ting was within 50 msec of the baseline setting, whereas in 22% of the cases the final
setting was between 50-250 msec.
Conclusion: AV delay optimization using Doppler echocardiography and the Ritter
method in patients undergoing CRT results in a significant change in the final AV delay
setting in only 22% of the cases. These data would suggest that AV delay optimization is
not necessary in most patients undergoing CRT. Further investigation attempting to tar-
get patients likely to benefit from an AV optimization procedure is needed.
11:15 a.m.
879-4 Cardiac Resynchronization Therapy Improves Sleep 
Related Breathing Disorders in Patients With Chronic 
Heart Failure
Karlheinz Seidl, Monika Rameken, Thorsten Becker, Margit Vater, Jochen Senges, Heart 
Center, Ludwigshafen, Germany
Background: About 40 - 50% of patients (pts) with advanced heart failure (CHF) present
with sleep related breathing disorders (SRBD) primarily they present with central sleep
apnea syndrome.
Aim of the study was 1) to assess, how many pts with CHF have additionally a SRBD. 2)
to evaluate the effect of cardiac resynchronisation therapy (CRT) on SRBD in these pts.
Methods: Overnight polysomnography was performed in 55 pts with CHF and left bundle
branch block (41 male; 65 ± 11 years, reduced ejection fraction (26 ± 6%) and NYHA III).
If the apnea/hypopnea index (AHI) was > 10 during baseline polysomnography "with CRT
off", a second overnight polysomnography was performed "with CRT on".
Results: 21 pts (38%) had a AHI >10, in 15 pts (71%) a central and in 6 pts (29%) a
obstructive form of SRBD was present at baseline. Compared to baseline values AHI
was significantly improved from 49 ± 35 to 14 ± 10 (p=0.01), whereas the noctural mini-
mal oxygen saturation significantly increased from 85 ± 6% to 91 ± 5% (p=0.02) with
"CRT on". No improvement was seen in pts with an obstructive form of SRBD.
RV  Bi-V
Mean ± S.D Fixed Rate Fixed Rate Pseudo AF
LV dp/dt max (mmHg/sec)  809 ± 110  978 ± 126.5* 975.8 ± 89.5
Arterial Pulse Pressure (mmHg)  33.6 ± 6.6  37.5 ± 9.8  37.5 ± 7.6
Arterial Mean Pressure (mmHg)  79.5 ± 14.7  83.3 ± 11.4  82.2 ± 11.6
Arterial Systolic Pressure (mmHg)  99.3 ± 12.7 105.5 ± 10 104.2 ± 10.2
LV end diastolic pressure (mmHg)  21.8 ± 8.02  19.3 ± 7.06*  18.9 ± 6.6
LV dp/dt min (mmHg/sec) -785.1 ± 170.2 -965.6 ± 186* -912 ± 185¶
* p<0.05 ( compared to RV)
¶ p<0.05 ( Fixed rate compared to Pseudo AF)
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Conclusion: 1) SRBD was observed in about 1/3 of pts with advanced CHF. 2/3 had a
central form of SRBD. 2) CRT significantly improves AHI and noctural minimal oxygen
saturation in pts with CHF and "CRT on".
11:30 a.m.
879-5 Mechanical Activation Mapping With Strain Imaging: A 
New Approach to Localize Ventricular Lead Placement 
After Cardiac Resynchronization Therapy
Hideaki Kanzaki, Raveen Bazaz, David Schwartzman, Kaoru Dohi, John Gorcsan, III, 
University of Pittsburgh, Pittsburgh, PA
Background: Cardiac resynchronization therapy (CRT) can be beneficial for patients
with heart failure (HF) and left bundle branch block (LBBB). Left ventricular (LV) leads for
CRT are being placed in variable epicardial locations.
Methods: To test the hypothesis that a new mechanical activation mapping method using
echocardiographic strain imaging can localize LV lead placement after CRT, 24 HF
patients with LBBB (EF 24 ± 5%, QRS 164 ± 29 ms) were studied at baseline and the
day after CRT. Strain imaging cineloops were acquired (Vivid 5 or 7, GE Vingmed) from 3
routine apical views: 4-chamber, 2-chamber, and long-axis. The activation maps were
constructed with time-to-peak systolic strain at basal and mid LV walls from each apical
view (12 sites).
Results: At baseline, the earliest mechanical activation occurred at septal sites in 18
(75%), and propagated latest to basal lateral or posterior sites in 19 (79%). After CRT,
the earliest activation site appeared at mid septal-inferior and free wall sites, presumably
from right ventricular apical and LV free wall pacing. The site of LV lead placement (lat-
eral 10, posterolateral 9, anterior 3, anterolateral 1, posterior 1) was identified by the
mapping with the shortest time-to-peak strain in accurate or contiguous LV anatomical
site in 88% (Kappa value 0.88).
Conclusion: Echocardiographic strain mapping revealed changes in the mechanical
activation sequence after CRT and successfully localized LV lead position, which has
promise for clinical utility.
11:45 a.m.
879-6 Left Ventricular Pre-Excitation Is Superior to Right 
Ventricular Pre-Excitation in Sequential Biventricular 
Pacing for Heart Failure
Ilan Hay, Vojta Melenovsky, Barry J. Fetics, Joshua Hare, Daniel Judge, Andrew Kramer, 
Craig Reister, Joe Pastore, Rick Conville, David A. Kass, Ronald Berger, Johns Hopkins 
Medical Institution, Baltimore, MD, Guidant Co., St. Paul, MN
Cardiac resynchronization (CRT) is commonly provided with simultaneous bi-ventricular
pacing; however, sequential Bi-V pacing may be superior. Prior data suggests that overly
premature LV or RV stimulation similarly reduces the effectiveness of CRT. We tested this
hypothesis in nine patients with cardiac failure (EF<30%) and atrial fibrillation. Patients
with marked bradycardia or following AV node ablation were studied to eliminate con-
founding effects of native AV conduction. Bi-V pacing employed an RV-apical and LV-pos-
tero-lateral lead, with RV-LV timing delay varied between -120 msec (RV early) to +120
msec (LV early). In addition, we compared RV only to LV only and Bi-V pacing modes.
Ventricular and aortic pressure data were measured for one minute with each pacing
mode (Table)
Preexcitation of the LV was superior to RV for each time interval tested. Marked pre-exci-
tation of the LV was significantly better than with RV (14.8 ± 2.5% rise in dp/dtmax RV vs
LV, p<0.05). Optimal results were at or near simultaneous activation. Importantly, 120
msec LV pre-excitation was very similar to LV only pacing (14.4 ±2.7 %, better than RV
only), but not as good as Bi-V (21.4 ± 0.76 % over RV, p<0.05). Diastolic function (dp/
dtmin) was also better with synchronized Bi-V pacing and declined with increasing RV-LV
delay intervals for both pre-excitation sequences. We conclude that LV pre-excitation is
superior to RV pre-excitation but offers no advantage over Bi-V pacing in patients without
any supraventricular conduction.
ORAL CONTRIBUTIONS
890 
Ischemic Ventricular Tachyarrhythmias
Wednesday, March 10, 2004, 10:30 a.m.-Noon
Morial Convention Center, Room 254
10:30 a.m.
890-1 Does a Narrow QRS Identify a Low-Risk Subgroup of 
Patients With Ischemic Heart Disease? Results of 
Electrophysiology Testing and T Wave Alternans 
Testing in a "MADIT-2" Population
Kenneth M. Stein, Sei Iwai, Suneet Mittal, Steven M. Markowitz, Ravi K. Yarlagadda, 
Bindi K. Shah, Amit B. Guttigoli, Bruce B. Lerman, Cornell University Medical Center, 
New York, NY
Background: Retrospective analysis of the MADIT-2 database has suggested that the
population with a narrow QRS complex derives less benefit from ICD implantation than
the population with a wide QRS complex. We sought to determine whether the results of
EP-testing (EPS) and T wave alternans testing (TWA) in a population with severe left
ventricular dysfunction and prior myocardial infarction were consistent with this hypothe-
sis.
Methods: We prospectively evaluated 67 patients (53 men, mean age 68±9 yrs) who
were referred for EPS for risk stratification (n=59) or due to a history of syncope or pre-
syncope (n=8). All patients had documented coronary artery disease and a prior myocar-
dial infarction and all had an LVEF < 30% (mean: 25±5%). All pts underwent TWA testing
during rapid atrial pacing (550 msec) with the Cambridge Heart CH2000 system or
HearTwave system at the time of EPS. TWA was interpreted using standard criteria by
two physicians blinded to the results of EPS. The EPS protocol used programmed stimu-
lation at two ventricular sites with up to triple extrastimuli with and without isoproterenol
or dobutamine. Positive EPS was defined as the induction of sustained monomorphic
ventricular tachycardia with up to triple ventricular extrastimuli. A wide QRS was defined
as a QRS duration > 120 msec.
Results: Among the 31 patients with a wide QRS, 65% had positive EP studies vs. 67%
among the 36 patients with a narrow QRS (p=NS). Among patients with a wide QRS 58%
had a positive TWA test vs. 47% with a narrow QRS (p=NS). Excluding patients with
indeterminate TWA tests the positivity rates were 72% and 59% respectively (p=NS). In
fully 90% of wide QRS patients and 81% of narrow QRS patients at least one of the 2
tests (EPS, TWA) was positive (p=NS).
Conclusion: The likelihood of a positive electrophysiologic study and/or TWA test is
remarkably high in a population with ischemic cardiomyopathy and LVEF < 30%, irre-
spective of whether the baseline QRS is wide or narrow. These data do not support the
concept that a narrow QRS identifies a low-risk subpopulation of "MADIT-2"-type
patients.
10:45 a.m.
890-2 Initial Results From the Substrate Mapping and Ablation 
in Sinus Rhythm to Halt Ventricular Tachycardia Trial 
(SMASH VT)
Vivek Y. Reddy, Allison W. Richardson, Petr Neuzil, Krit Jongnarangsin, Stepan Kralovec, 
Lucie Sediva, Milos Taborsky, Matt Reynolds, Mark E. Josephson, Beth Israel-
Deaconess Medical Center, Boston, MA, Na Homolce Hospital, Prague, Czech Republic
Background: In post-MI patients, implantable cardioverter-defibrillators (ICDs) are effec-
tive in terminating ventricular tachycardia (VT) and fibrillation (VF). However, ICD shocks
are painful and do not prevent syncope, and antiarrhythmic drugs (AAD) are often
required. Substrate based catheter ablation has been shown to decrease events in
patients who have received multiple ICD shocks. In this multicenter prospective random-
ized controlled trial, we examined the role of substrate ablation in the primary prevention
of appropriate ICD shocks in high-risk post-MI patients.
←  RV  Pre-Excitation  Interval   LV  Pre-excitation  interval  →
Mean ± S.D RV 
only
80
msec
40
msec
Simul
taneous
40
msec
80
msec 
120
msec
LV
dp/dt max (mmHg/sec)
791 ±
85 *
824±
73 *
885±
107 *
983 ±
138
983 ±
126
961±
117
906±
100*
Arterial
Pulse Pressure 
(mmHg)
34 ±
8.2*
35.7 ±
8.8*
36.5 ±
8.9*
38.6±
9.5
36.8 ±
9.6
37 ±
9.6
34.4 ±
9.6*
Arterial
Mean Pressure 
(mmHg)
80.1 ±
13.5*
81.9 ±
12.9*
82.5±
12.7
84.9 ±
13
83.7 ±
12.6
82.6±
11
80.7±
11.2 *
LV
dp/dt min(mmHg/sec)
-804±
201*
-862±
200*
-891±
206 *
-937±
189
-914±
166
-882±
160*
-852±
171*
* P < 0.05 ( Repetitive ANOVA with Tukey Correction for post hoc Comparisons) 
Compared with Simultaneous Pacing.
